MX338223B - Emulsion de grasas para alimentar artificialmente a pacientes seriamente enfermos en cuidados intensivos. - Google Patents
Emulsion de grasas para alimentar artificialmente a pacientes seriamente enfermos en cuidados intensivos.Info
- Publication number
- MX338223B MX338223B MX2011005201A MX2011005201A MX338223B MX 338223 B MX338223 B MX 338223B MX 2011005201 A MX2011005201 A MX 2011005201A MX 2011005201 A MX2011005201 A MX 2011005201A MX 338223 B MX338223 B MX 338223B
- Authority
- MX
- Mexico
- Prior art keywords
- fat emulsion
- intensive care
- seriously ill
- care patients
- artificially feeding
- Prior art date
Links
- 239000002960 lipid emulsion Substances 0.000 title abstract 2
- 208000035902 Critical illness myopathy Diseases 0.000 abstract 2
- 206010036105 Polyneuropathy Diseases 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 206010066336 critical illness polyneuropathy Diseases 0.000 abstract 2
- 125000005313 fatty acid group Chemical group 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Dispersion Chemistry (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Food Science & Technology (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a una formulación farmacéutica para la profilaxis y tratamiento de la enfermedad de polineuropatía crítica y la enfermedad de miopatía crítica. La invención además se refiere a una emulsión de grasas isotónicas que comprende por lo menos un triglicérido que comprende por lo menos un grupo de ácido graso que tiene un número impar de átomos de carbono, en donde el grupo de ácido graso comprende una cadena de carbono que tiene de 5 a 15 átomos de carbono.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008057867A DE102008057867A1 (de) | 2008-11-18 | 2008-11-18 | Fettemulsion zur künstlichen Ernährung von schwerkranken Intensivpatienten |
PCT/EP2009/064839 WO2010057804A1 (de) | 2008-11-18 | 2009-11-09 | Fettemulsion zur künstlichen ernährung von schwerkranken intensivpatienten |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2011005201A MX2011005201A (es) | 2011-06-01 |
MX338223B true MX338223B (es) | 2016-04-08 |
Family
ID=41581163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011005201A MX338223B (es) | 2008-11-18 | 2009-11-09 | Emulsion de grasas para alimentar artificialmente a pacientes seriamente enfermos en cuidados intensivos. |
Country Status (12)
Country | Link |
---|---|
US (2) | US20110207819A1 (es) |
EP (1) | EP2355813B1 (es) |
JP (1) | JP2012509292A (es) |
KR (1) | KR20110084513A (es) |
CN (1) | CN102215839B (es) |
BR (1) | BRPI0921917B8 (es) |
CA (1) | CA2739390C (es) |
DE (1) | DE102008057867A1 (es) |
ES (1) | ES2561207T3 (es) |
MX (1) | MX338223B (es) |
RU (1) | RU2528108C2 (es) |
WO (1) | WO2010057804A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009013914B4 (de) * | 2009-03-19 | 2011-05-05 | Bruker Daltonik Gmbh | Kalibriersubstanzen für Atmosphärendruck-Ionenquellen |
AU2012211854A1 (en) * | 2011-01-31 | 2013-08-08 | Nagoya Industrial Science Research Institute | Prophylactic or therapeutic drug for peripheral neuropathy caused by anticancer agent |
US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
CN106900888B (zh) * | 2015-12-23 | 2021-12-24 | 丰益(上海)生物技术研发中心有限公司 | 含有奇数碳脂肪酸结构脂的油脂组合物及其应用 |
WO2017211274A1 (en) * | 2016-06-08 | 2017-12-14 | Dong Yuhong | Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement |
CN109602704A (zh) * | 2019-01-23 | 2019-04-12 | 广东嘉博制药有限公司 | 丁酸氯维地平脂肪乳注射液及其制备工艺 |
CN110326789A (zh) * | 2019-06-11 | 2019-10-15 | 上海互众药业有限公司 | 一种脂肪乳食品补充液及其制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2515174A1 (fr) | 1981-10-23 | 1983-04-29 | Roussel Uclaf | Nouveaux triglycerides, procede de preparation et d'applications en dietetique et en therapeutique |
US4526902A (en) | 1983-10-24 | 1985-07-02 | Century Laboratories, Inc. | Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions |
DE3721137A1 (de) | 1987-06-26 | 1989-01-05 | Dietl Hans | Fettemulsion zur intravenoesen anwendung |
DE3722540A1 (de) | 1987-07-08 | 1989-01-19 | Fresenius Ag | Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung |
DE3734147C2 (de) * | 1987-10-09 | 1998-10-29 | Braun Melsungen Ag | Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung |
AU682894B2 (en) * | 1993-10-28 | 1997-10-23 | Institut National De La Recherche Agronomique | Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man |
RU2155612C2 (ru) * | 1997-01-30 | 2000-09-10 | Скрипченко Наталия Викторовна | Способ лечения острых инфекционных заболеваний периферической нервной системы |
MXPA01007988A (es) * | 1999-02-05 | 2003-07-14 | Baylor University Medical Ct | Suplemento nutricional o preparacion farmaceutica que comprende trigliceridos con acido graso de siete carbonos. |
US6740679B1 (en) | 1999-02-05 | 2004-05-25 | Baylor University Medical Center | Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
US20030162833A1 (en) * | 2001-08-01 | 2003-08-28 | Roe Charles R. | Fatty acid treatment for cardiac patients |
IL161310A0 (en) * | 2001-10-11 | 2004-09-27 | Applied Research Systems | Use of a substance signaling through gp 130 in pns disorders |
WO2004103307A2 (en) * | 2003-05-20 | 2004-12-02 | Baylor Research Institute | Method of use of five and fifteen carbon fatty acids |
CA2784420C (en) * | 2004-07-02 | 2020-11-10 | Baylor Research Institute | Glycogen or polysaccharide storage disease treatment method |
DE502005000555D1 (de) * | 2005-02-16 | 2007-05-16 | Streatmans Chemische Produktio | Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an chemischen UV-Filtern und Triheptanonin |
EP2083813A4 (en) | 2006-09-26 | 2011-04-27 | Baylor Res Inst | NUTRIENT SENSOR |
-
2008
- 2008-11-18 DE DE102008057867A patent/DE102008057867A1/de not_active Withdrawn
-
2009
- 2009-11-09 EP EP09760502.6A patent/EP2355813B1/de active Active
- 2009-11-09 KR KR1020117010418A patent/KR20110084513A/ko not_active Application Discontinuation
- 2009-11-09 ES ES09760502.6T patent/ES2561207T3/es active Active
- 2009-11-09 CA CA2739390A patent/CA2739390C/en active Active
- 2009-11-09 JP JP2011536823A patent/JP2012509292A/ja active Pending
- 2009-11-09 WO PCT/EP2009/064839 patent/WO2010057804A1/de active Application Filing
- 2009-11-09 CN CN200980145702.6A patent/CN102215839B/zh not_active Ceased
- 2009-11-09 MX MX2011005201A patent/MX338223B/es active IP Right Grant
- 2009-11-09 US US13/126,245 patent/US20110207819A1/en not_active Abandoned
- 2009-11-09 BR BRPI0921917A patent/BRPI0921917B8/pt active IP Right Grant
- 2009-11-09 RU RU2011124887/15A patent/RU2528108C2/ru active
-
2015
- 2015-11-03 US US14/930,723 patent/US20160051506A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2355813B1 (de) | 2015-11-04 |
RU2011124887A (ru) | 2012-12-27 |
JP2012509292A (ja) | 2012-04-19 |
BRPI0921917A2 (pt) | 2015-12-29 |
ES2561207T3 (es) | 2016-02-25 |
RU2528108C2 (ru) | 2014-09-10 |
BRPI0921917B1 (pt) | 2020-08-25 |
US20110207819A1 (en) | 2011-08-25 |
KR20110084513A (ko) | 2011-07-25 |
WO2010057804A1 (de) | 2010-05-27 |
MX2011005201A (es) | 2011-06-01 |
BRPI0921917B8 (pt) | 2021-05-25 |
CN102215839B (zh) | 2016-08-24 |
CN102215839A (zh) | 2011-10-12 |
EP2355813A1 (de) | 2011-08-17 |
US20160051506A1 (en) | 2016-02-25 |
DE102008057867A1 (de) | 2010-05-20 |
CA2739390C (en) | 2016-05-03 |
CA2739390A1 (en) | 2010-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX338223B (es) | Emulsion de grasas para alimentar artificialmente a pacientes seriamente enfermos en cuidados intensivos. | |
CY1123549T1 (el) | Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης | |
IN2012DN02661A (es) | ||
CY1123227T1 (el) | Παρασκευασμα θεραπειας ουλης με σιλικονη | |
MX2014004722A (es) | Composicion para ser usada en la promocion del crecimiento de hueso sano y/o en la prevencion y/o tratamiento de la enfermedad osea. | |
ECSP10010289A (es) | Régimen de dosificación asociado con ésteres de paliperidona inyectables de acción prolongada | |
PH12015500407A1 (en) | Methods of treating hypertriglyceridemia | |
CU20140151A7 (es) | Composición farmacéutica útil en la prevención de un evento cardiovascular mayor | |
MX2012004525A (es) | Compuestos. | |
AU2016219643A1 (en) | Pharmaceutical combination for the treatment of pain | |
PE20110592A1 (es) | Compuestos nutricionales para promover el desarrollo de la salud y el crecimiento | |
BR112015014420A2 (pt) | oligossacarídeos do leite humano para melhorar sintomas de estresse | |
MY170185A (en) | Composition for use in brain growth and/or cognitive and/or psychomotor development | |
PH12018500090A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
RU2014153787A (ru) | Лечение и профилактика сердечно-сосудистого заболевания и тромбоза | |
MX360554B (es) | Composiciones que comprenden y metodos que utilizan inhibidores de co-transportadores de glucosa-sodio 1 y 2. | |
IN2014DN02346A (es) | ||
EA201492127A1 (ru) | Пролекарственные производные (е)-n-метил-n-((3-метилбензофуран-2-ил)метил)-3-(7-оксо-5,6,7,8-тетрагидро-1,8-нафтиридин-3-ил)акриламида | |
WO2010136900A3 (en) | Methods of using krill oil to treat risk factors for metabolic disorders and obesity | |
FR2953964B1 (fr) | Procede de traitement d'images obtenues par tomographie ou tomosynthese a faible nombre de projections | |
PH12018500035A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
ECSP13012798A (es) | Método para inhibir patógenos usando una composición nutricional | |
BR112013026680A2 (pt) | composto, método de tratamento de uma doença inflamatória e composição farmacêutica | |
SG190952A1 (en) | Compositions and methods for treating amyloid plaque associated symptoms | |
IN2014DN10798A (es) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |